VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,873,035 | -10.6% | 738,500 | 0.0% | 80.92% | +15.3% |
| Q2 2023 | $22,236,235 | -6.9% | 738,500 | 0.0% | 70.19% | -4.2% |
| Q1 2023 | $23,890,475 | +12.9% | 738,500 | 0.0% | 73.26% | +4.9% |
| Q4 2022 | $21,165,410 | +18.8% | 738,500 | 0.0% | 69.82% | +15.3% |
| Q3 2022 | $17,813,000 | -11.9% | 738,500 | 0.0% | 60.55% | -9.4% |
| Q2 2022 | $20,220,000 | -28.6% | 738,500 | 0.0% | 66.82% | +103.8% |
| Q1 2022 | $28,321,000 | +19.7% | 738,500 | 0.0% | 32.79% | +120.6% |
| Q4 2021 | $23,654,000 | +8.7% | 738,500 | 0.0% | 14.86% | +9.6% |
| Q3 2021 | $21,764,000 | -13.3% | 738,500 | 0.0% | 13.56% | -17.3% |
| Q2 2021 | $25,094,000 | +4.6% | 738,500 | 0.0% | 16.41% | +10.9% |
| Q1 2021 | $24,001,000 | -9.8% | 738,500 | 0.0% | 14.79% | +31.4% |
| Q4 2020 | $26,601,000 | – | 738,500 | – | 11.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |